Work

TRIM27 is an adverse prognostic biomarker and associated with immune and molecular profiles in right-sided colon cancer.

Year: 2022

Type: article

Abstract: T cells. These results indicated that TRIM27 could be a promising therapeutic target in RCC.

Source: PubMed Central

Authors: Minghui Zhang, Bowen Yang, Lingyun Zhang, Xiaoyu Guo, Guangwei Zhang, Xiaofang Che, Ce Li, Kezuo Hou, Xiaojie Zhang, Jinglei Qu, Ti Wen, Xiujuan Qu

Institution: First Hospital of China Medical University

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4311285796

FWCI:

Cites: 59

Cited by:

Related to: 10